Jump to the main content block

Online Speech: Introduction of RadioTheranostics: Molecular Imaging and Therapy

活動時間:112年4月21日(五) 下午12:10-13:10PM
講題: Introduction of RadioTheranostics: Molecular Imaging and Therapy
講師: Yale Positron Emission Tomography(PET) Center, Yale University / Dr. Ming-Kai Chen

The concept of “theranostics” is a strategy involving both diagnostics and therapeutics. Radiotheranostics is using specific radionuclide-labeled pharmaceuticals for both diagnosis and therapy of diseases. I-131 radioactive iodine has been widely used for diagnosis and treatment of hyperthyroid and thyroid cancer. Recently, peptide receptor radionuclide therapy (PRRT) in combination of molecular peptide receptor imaging has become a successful strategy for neuroendocrine tumors (NETs). Prostate-specific membrane antigen (PSMA) based molecular imaging and targeted therapy for prostate cancer will transform the management of oncologic patients soon. The theranostic principle has established a foundation for further expansion of promising agents into other diseases.



Click Num: